ADT includes induction of hypogonadism through orchiectomy and a luteinizing hormone-releasing hormone (LH-RH) agonist, alone or combined with an androgen blockade (LH-RH agonist plus antiandrogen) [8]. Here, GNRH1 is linked to hypogonadism.